PATENT CLAIM ANALYSIS

Application Number: 16403176
Application Type: Utility
Filing Date: 2019-05
Publication Date: 2019-08
Patent Classification: ["424", "489000"]

Abstract:
Embodiments are directed to a secnidazole formulations and the use of a secnidazole formulation for the treatment of bacterial vaginosis (BV).

Claim (Index 66):
The single dose pharmaceutical composition of  claim 53 , wherein the subject is a female having had bacterial vaginosis 4 or more times within the past 12 months.

Metadata:
- Claim Count in Document: 146.0
- Percentile: 100.0
- Lexical Diversity: 1.2
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14846505', '16049032', '13472953', '15990010', '13982675']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7846904829428826
- 35 USC 102 Novelty (BERT): 0.7021432631870744
- Combined Prediction Score: 0.7764357609673018
- Mean Citation Score: 462.23057400000016
- Max Citation Score: 835.29974
- Similarity Product: 641.8669350840198

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test